Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.
Tumor Microenvironment Center, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA 15232.
Immunohorizons. 2021 Jan 22;5(1):48-58. doi: 10.4049/immunohorizons.2000098.
TRAIL (/TRAIL/CD253/Apo2L) is an important immune molecule that mediates apoptosis. TRAIL can play key roles in regulating cell death in the tumor and autoimmune microenvironments. However, dissecting TRAIL function remains difficult because of the lack of optimal models. We have now generated a conditional knockout ( ) for cell type-specific analysis of TRAIL function on C57BL/6, BALB/c, and NOD backgrounds. Previous studies have suggested a role for TRAIL in regulatory T cell (T)-mediated suppression. We generated mice with a T-restricted deletion and surprisingly found no impact on tumor growth in C57BL/6 and BALB/c tumor models. Furthermore, we found no difference in the suppressive capacity of -deficient T and no change in function or proliferation of T cells in tumors. We also assessed the role of TRAIL on T in two autoimmune mouse models: the NOD mouse model of autoimmune diabetes and the myelin oligodendrocyte glycoprotein (MOG) C57BL/6 model of experimental autoimmune encephalomyelitis. We found that deletion of on T had no effect on disease progression in either model. We conclude that T do not appear to be dependent on TRAIL exclusively as a mechanism of suppression in both the tumor and autoimmune microenvironments, although it remains possible that TRAIL may contribute in combination with other mechanisms and/or in different disease settings. Our conditional knockout mouse should prove to be a useful tool for the dissection of TRAIL function on different cell populations in multiple mouse models of human disease.
TRAIL(/TRAIL/CD253/Apo2L)是一种重要的免疫分子,介导细胞凋亡。TRAIL 在肿瘤和自身免疫微环境中调节细胞死亡方面发挥着关键作用。然而,由于缺乏最佳模型,解析 TRAIL 功能仍然具有挑战性。我们现在已经生成了一种条件性敲除(),用于在 C57BL/6、BALB/c 和 NOD 背景下对 TRAIL 功能进行细胞类型特异性分析。先前的研究表明 TRAIL 在调节性 T 细胞(T 细胞)介导的抑制中发挥作用。我们生成了 T 细胞受限的缺失小鼠,令人惊讶的是,在 C57BL/6 和 BALB/c 肿瘤模型中,这对肿瘤生长没有影响。此外,我们没有发现 -缺陷 T 细胞的抑制能力有差异,也没有发现 T 细胞在肿瘤中的功能或增殖发生变化。我们还评估了 TRAIL 在两种自身免疫性小鼠模型中的作用:自身免疫性糖尿病的 NOD 小鼠模型和实验性自身免疫性脑脊髓炎的 MOG C57BL/6 模型。我们发现 T 细胞上的缺失对这两种模型中的疾病进展均无影响。我们得出结论,T 细胞似乎不依赖 TRAIL 作为其在肿瘤和自身免疫微环境中抑制的唯一机制,尽管 TRAIL 可能与其他机制结合或以不同的疾病状态发挥作用仍有可能。我们的条件性敲除小鼠应该证明是在多种人类疾病的小鼠模型中对不同细胞群体的 TRAIL 功能进行剖析的有用工具。